The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals
Abstract
The popular recreational drug, (±)3,4-methylenedioxymethamphetamine (MDMA; ‘Ecstasy’) is a potent and selective brain serotonin (5-HT) neurotoxin in animals. MDMA-induced 5-HT neurotoxicity can be demonstrated using a variety of neurochemical, neuroanatomical and, more recently, functional measures of 5-HT neurons. Although the neurotoxic effects of MDMA in animals are widely accepted, the relevance of the animal data to human MDMA users has been questioned, largely because dosages of drugs used in animals are perceived as being much higher than those used by humans. In the present paper, we review the extensive body of data demonstrating that MDMA produced toxic effects on brain 5-HT neurons in animals and present new data indicating that levels of the type 2 vesicular monoamine transporter are reduced in MDMA-treated animals, providing further indication of MDMA’s 5-HT neurotoxic potential. Further, we demonstrate, using principles of interspecies scaling, that dosages of MDMA known to be neurotoxic in animals fall squarely in the range of dosages used typically by recreational MDMA users.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schneider, G. E. (1973) · Brain, Behavior and Evolution · doi:10.1159/000124348 · Cited by 545
O'Hearn, E., Battaglia, G., De Souza, E., Kuhar, M., & Molliver, M. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02788.1988 · Cited by 542
Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.
Schmidt, C. J. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22673-8 · Cited by 529
Battaglia, G., Yeh, S. Y., O'Hearn, E., Molliver, M. E., Kuhar, M. J., & De Souza, E. B. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39191-3 · Cited by 458
Commins, D. L., Vosmer, G., Virus, R. M., Woolverton, W. L., Schuster, C. R., & Seiden, L. S. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00317-9 · Cited by 453
Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals
Ricaurte, G., Bryan, G., Strauss, L., Seiden, L., & Schuster, C. (1985) · Science · doi:10.1126/science.4023719 · Cited by 367
Self-citationStone, D. M., Stahl, D. C., Hanson, G. R., & Gibb, J. W. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90555-8 · Cited by 346
Hatzidimitriou, G., McCann, U. D., & Ricaurte, G. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05096.1999 · Cited by 339
Self-citationPresynaptic monoaminergic vesicles in Parkinson's disease and normal aging
Frey, K. A., Koeppe, R. A., Kilbourn, M. R., Vander Borght, T. M., Albin, R. L., Gilman, S., & Kuhl, D. E. (1996) · Annals of Neurology · doi:10.1002/ana.410400609 · Cited by 314
MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons
Battaglia, G., Yeh, S. Y., & De Souza, E. B. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90155-4 · Cited by 312
Ricaurte, G. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410010059035 · Cited by 300
Self-citationSTEELE, T. D., McCANN, U. D., & RICAURTE, G. A. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb03330.x · Cited by 289
Self-citationFischer, C., Hatzidimitriou, G., Wlos, J., Katz, J., & Ricaurte, G. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05476.1995 · Cited by 268
Self-citationRicaurte, G. A., Martello, A. L., Katz, J. L., & Martello, M. B. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11083-5 · Cited by 268
Self-citationNeurotoxicity of MDMA and Related Compounds: Anatomic Studiesa
MOLLIVER, M. E., BERGER, U. V., MAMOUNAS, L. A., MOLLIVER, D. C., O'HEARN, E., & WILSON, M. A. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16916.x · Cited by 252
Ricaurte, G. A., DeLanney, L. E., Irwin, I., & Langston, J. W. (1988) · Brain Research · doi:10.1016/0006-8993(88)91309-1 · Cited by 245
Self-citationO'Shea, E., Granados, R., Esteban, B., Colado, M. I., & Green, A. R. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00029-x · Cited by 242
The vesicular monoamine transporter is not regulated by dopaminergic drug treatments
Borght, T. V., Kilbourn, M., Desmond, T., Kuhl, D., & Frey, K. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00594-3 · Cited by 205
Methylenedioxymethamphetamine: A potentially neurotoxic amphetamine analogue
Schmidt, C. J., Wu, L., & Lovenberg, W. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90140-8 · Cited by 202
Schmidt, C. J., & Taylor, V. L. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90566-1 · Cited by 187
Insel, T. R., Battaglia, G., Johannessen, J. N., Marra, S., & De Souza, E. B. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23487-5 · Cited by 162
Wilson, M. A., Ricaurte, G. A., & Molliver, M. E. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90237-6 · Cited by 156
Self-citationScheffel, U., Szabó, Z. R., Mathews, W. B., Finley, P. A., Dannals, R. F., Ravert, H. T., Szabo, K., Yuan, J., & Ricaurte, G. A. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199806)29:2<183::aid-syn9>3.0.co;2-3 · Cited by 143
Self-citationFritschy, J., & Grzanna, R. (1992) · The Journal of Comparative Neurology · doi:10.1002/cne.903210309 · Cited by 142
Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats.
Scanzello, C. R., Hatzidimitriou, G., Martello, A. L., Katz, J. L., & Ricaurte, G. A. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10168-7 · Cited by 135
Self-citationSTONE, D., Gr, H., & Gibb, J. W. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90017-7 · Cited by 131
Slikker, W., Ali, S. F., Scallet, A. C., Frith, C. H., Newport, G. D., & Bailey, J. (1988) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(88)90285-2 · Cited by 110
Extrapolation of Toxicological and Pharmacological Data from Animals to Humans
Chappell, W. R., & Mordenti, J. J. (1991) · Advances in Drug Research · doi:10.1016/b978-0-12-013320-8.50005-8 · Cited by 108
Sabol, K. E., Lew, R., Richards, J. B., Vosmer, G. L., & Seiden, L. S. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12371-9 · Cited by 106
Lew, R., Sabol, K. E., Chou, C., Vosmer, G. L., Richards, J. B., & Seiden, L. S. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12372-0 · Cited by 93
Axonal transport in serotonin neurons of the midbrain raphe
Halaris, A. E., Jones, B. E., & Moore, R. Y. (1976) · Brain Research · doi:10.1016/0006-8993(76)90144-x · Cited by 86
Frankfurt, M., & Azmitia, E. C. (1984) · Brain Research · doi:10.1016/0006-8993(84)91426-4 · Cited by 67
DEVELOPMENTAL PLASTICITY OF CENTRAL SEROTONIN NEURONS AFTER 5,7‐DIHYDROXYTRYPTAMINE TREATMENT*
JONSSON, G., Pollare, T., Hallman, H., & Sachs, C. (1978) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1978.tb31532.x · Cited by 66
Aguirre, N., Barrionuevo, M., Lasheras, B., & Río, J. D. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37706-7 · Cited by 59
Sachs, C., & JONSSON, G. (1975) · PubMed · Cited by 59
Orally administered MDMA causes a long-term depletion of serotonin in rat brain
Finnegan, K. T., Ricaurte, G. A., Ritchie, L. D., Irwin, I., Peroutka, S. J., & Langston, J. W. (1988) · Brain Research · doi:10.1016/0006-8993(88)90974-2 · Cited by 56
Self-citationAli, S. F., Newport, G. D., Scallet, A. C., BINIENDA, Z. K., Ferguson, S. A., Bailey, J. R., Paule, M. G., & SLIKKERJR, W. (1993) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(93)90067-x · Cited by 55
Naudon, L., Leroux‐Nicollet, I., & Costentin, J. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90136-8 · Cited by 55
Gustafson, E. L., & Moore, R. Y. (1987) · Developmental Brain Research · doi:10.1016/0165-3806(87)90236-7 · Cited by 35
Changes in the development of central noradrenaline neurons after neonatal axon lesions
JONSSON, G., & Sachs, C. (1982) · Brain Research Bulletin · doi:10.1016/0361-9230(82)90168-x · Cited by 29
REVIEW ■ : Long-lasting Effects of Recreational Drugs of Abuse on the Central Nervous System
McCann, U. D., Lowe, K. A., & Ricaurte, G. A. (1997) · The Neuroscientist · doi:10.1177/107385849700300613 · Cited by 23
Self-citationReactions of 5-HT Neurons to Drugs of Abuse: Neurotoxicity and Plasticity
Wilson, M. A., Mamounas, L. A., Fasman, K. H., Axt, K. J., & Molliver, M. E. (1993) · PsycEXTRA Dataset · doi:10.1037/e495922006-009 · Cited by 19
Positron emission tomography findings in heavy users of MDMA
Holland, J. A. (1999) · The Lancet · doi:10.1016/s0140-6736(05)75651-8 · Cited by 10
Cited by
Verdejo-García, A., Lawrence, A. J., & Clark, L. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.11.003 · Cited by 1,422
Ecstasy (MDMA): a review of its possible persistent psychological effects
Morgan, M. J. (2000) · Psychopharmacology · doi:10.1007/s002130000545 · Cited by 380
Serotonergic vulnerability and depression: assumptions, experimental evidence and implications
Jans, L. A. W., Riedel, W. J., Markus, C. R., & Blokland, A. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001920 · Cited by 374
Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research
Parrott, A. C. (2001) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.351 · Cited by 344
Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity
Parrott, A. C. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00711-0 · Cited by 324
Metadata
- Authors
- Ricaurte, G. A., Yuan, J., & McCann, U. D.
- Venue
- Neuropsychobiology
- Publisher
- S. Karger AG
- Published
- 2000
- Volume
- 42
- Issue
- 1
- Pages
- 5-10
- ISSN
- 0302-282X (ISSN-L)
- 1423-0224
- OpenAlex
- W2109698385
- Cited by
- 292
- References
- 43
- FWCI
- 29.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.